Lymphadenopathy: Difference between revisions

Jump to navigation Jump to search
(Undo revision 1716687 by Jose Loyola (talk))
Tag: Undo
 
(41 intermediate revisions by 4 users not shown)
Line 1: Line 1:
[[File:ImageLymphadenopathy.jpg|300px|thumb|right|Lymphadenopathy]]
__NOTOC__
__NOTOC__
{{Lymphadenopathy}}                                                                 
{{Lymphadenopathy}}                                                                 
{{CMG}},{{shyam}};{{AE}} {{ADS}}, {{RT}}
{{CMG}},{{shyam}};{{AE}} {{ADS}}, {{RT}} [[Ogechukwu Hannah Nnabude, MD]]
 
 
   
   
{{SK}} Lymph nodes enlarged; Enlarged lymph nodes; Lymphadenitis; Swollen lymph nodes; Swollen/enlarged lymph nodes<br>
{{SK}} Lymph nodes enlarged; Enlarged lymph nodes; Lymphadenitis; Swollen lymph nodes; Swollen/enlarged lymph nodes<br>
'''For patient information, click [[Xyz (patient information)|here]]'''
'''For patient information, click [[Xyz (patient information)|here]]'''


==[[Lymphadenopathy overview|Overview]]==
==Overview==
 
==[[Lymphadenopathy historical perspective|Historical Perspective]]==


==[[Lymphadenopathy classification|Classification]]==
==[[Lymphadenopathy classification|Classification]]==
Line 14: Line 16:
==[[Lymphadenopathy pathophysiology|Pathophysiology]]==
==[[Lymphadenopathy pathophysiology|Pathophysiology]]==


==[[Lymphadenopathy causes|Causes]]==
==Histopathology==
 
==Causes==


==[[Lymphadenopathy differential diagnosis|Differentiating Lymphadenopathy from other Diseases]]==
==[[Lymphadenopathy differential diagnosis|Differentiating Lymphadenopathy from other Diseases]]==
==[[Epidemiology and Demographics]]==


==[[Lymphadenopathy epidemiology and demographics|Epidemiology and Demographics]]==
==Laboratory Evaluation of Lymphadenopathy==
 
==[[Lymphadenopathy risk factors|Risk Factors]]==
 
==[[Lymphadenopathy screening|Screening]]==


==[[Lymphadenopathy natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
==Diagnostic Radiological Testing==


==Diagnosis==
[[Lymphadenopathy diagnostic criteria|Diagnostic criteria]] | [[Lymphadenopathy history and symptoms|History and Symptoms]] | [[Lymphadenopathy physical examination|Physical Examination]] | [[Lymphadenopathy laboratory findings|Laboratory Findings]] | [[Lymphadenopathy electrocardiogram|Electrocardiogram]] | [[Lymphadenopathy x ray|X-Ray Findings]] | [[Lymphadenopathy echocardiography and ultrasound|Echocardiography and Ultrasound]] | [[Lymphadenopathy CT scan|CT-Scan Findings]] | [[Lymphadenopathy MRI|MRI Findings]] | [[Lymphadenopathy other imaging findings|Other Imaging Findings]] | [[Lymphadenopathy other diagnostic studies|Other Diagnostic Studies]]


==Treatment==
==Treatment==
[[Lymphadenopathy medical therapy|Medical Therapy]] | [[Lymphadenopathy surgery|Surgery]] | [[Lymphadenopathy primary prevention|Primary Prevention]] | [[Lymphadenopathy secondary prevention|Secondary Prevention]] | [[Lymphadenopathy cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Lymphadenopathy future or investigational therapies|Future or Investigational Therapies]]
==Case Studies==
[[Lymphadenopathy case study one|Case #1]]
==Causes==
==Differentiating Lymphadenopathy from other Diseases==
* Lymphadenopathy must be differentiated from [[syphilis]], which may present as [[fever]], [[myalgias]], [[weight loss]], and [[lymph node]] enlargement.<ref name="pmid1590633">{{cite journal |vauthors=Deschenes J, Seamone CD, Baines MG |title=Acquired ocular syphilis: diagnosis and treatment |journal=Ann Ophthalmol |volume=24 |issue=4 |pages=134–8 |year=1992 |pmid=1590633 |doi= |url=}}</ref>
==Risk Factors==
*The most common risk factors in the development of lymphadenopathy, include:
:*Local soft-tissue infections
:*[[Upper respiratory tract infection]]
:*Foreign travel
'''MRI'''
*MRI is the most anatomically precise test for assessing lymphadenopathy. MRI is particularly useful for intraabdominal lymphadenopathy, which cannot be readily palpated via physical examination. MRI is more expensive than CT scan, so CT is preferred in general unless the clinical need for MRI arises.


== Treatment ==
*There is no treatment for lymphadenopathy; the mainstay of therapy is treating the underlying condition.<ref name="pmid24753638">{{cite journal |vauthors=Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A |title=Peripheral lymphadenopathy: approach and diagnostic tools |journal=Iran J Med Sci |volume=39 |issue=2 Suppl |pages=158–70 |year=2014 |pmid=24753638 |pmc=3993046 |doi= |url=}}</ref>
**Infectious lymphadenopathy responds well to prompt treatment with antibiotics, and usually leads to a complete recovery. However, it may take months, for swelling to disappear. The amount of time to recovery depends on the cause.
**Neoplastic (malignant) lymphadenopathy usually responds well to systemic chemotherapy.


==References==
==References==
Line 65: Line 38:
[[Category:Dermatology]]
[[Category:Dermatology]]
[[Category:Medical signs]]
[[Category:Medical signs]]
[[Category:Signs and symptoms]]
[[Category: Signs and symptoms]]


[[Category:Physical examination]]
[[Category: Physical examination]]




Line 73: Line 46:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
  [[Category:Up-To-Date]]
  [[Category: Up-To-Date]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Medicine]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Hematology]]
[[Category:Hematology]]

Latest revision as of 18:21, 26 November 2021

Lymphadenopathy


Lymphadenopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lymphadenopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lymphadenopathy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphadenopathy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphadenopathy

CDC on Lymphadenopathy

Lymphadenopathy in the news

Blogs on Lymphadenopathy

Directions to Hospitals Treating Lymphadenopathy

Risk calculators and risk factors for Lymphadenopathy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1],Shyam Patel [2];Associate Editor(s)-in-Chief: Amandeep Singh M.D.[3], Raviteja Guddeti, M.B.B.S. [4] Ogechukwu Hannah Nnabude, MD


Synonyms and keywords: Lymph nodes enlarged; Enlarged lymph nodes; Lymphadenitis; Swollen lymph nodes; Swollen/enlarged lymph nodes
For patient information, click here

Overview

Classification

Pathophysiology

Histopathology

Causes

Differentiating Lymphadenopathy from other Diseases

Epidemiology and Demographics

Laboratory Evaluation of Lymphadenopathy

Diagnostic Radiological Testing

Treatment

References



Template:WikiDoc Sources